Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review

被引:3
|
作者
Ge, Qichao [1 ,2 ]
Liu, Yang [1 ,2 ]
Yang, Fan [1 ]
Sun, Guangwei [3 ]
Guo, Jintao [1 ]
Sun, Siyu [1 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Gastroenterol, 36 Sanhao St, Shenyang 110004, Peoples R China
[2] China Med Univ, Innovat Res Ctr Integrated Canc Om, Shengjing Hosp, Shenyang 110004, Peoples R China
[3] China Med Univ, Shengjing Hosp, Innovat Engn Technol Res Ctr Cell Therapy, Shenyang 110022, Peoples R China
基金
中国国家自然科学基金;
关键词
gastrointestinal stromal tumor; whole-exome sequencing; germline mutation; familial disease; precision oncology; GERMLINE MUTATION; KIT; SUNITINIB; IMATINIB; REGORAFENIB; MULTICENTER; EFFICACY; FAILURE; SAFETY; GENE;
D O I
10.3390/ijms24010830
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Familial gastrointestinal stromal tumor (GIST) is a rare autosomal dominant genetic disorder with only a few affected families reported to date. Here, we report a case of familial GISTs harboring a novel germline mutation within exon 18 of KIT. A 58-year-old male patient presented with gastric subepithelial lesions accompanied by cutaneous hyperpigmentation, which were subsequently diagnosed as multinodular GISTs. Endoscopic surgery was initially conducted to remove the larger lesions, and pathological examinations were then conducted for the diagnosis of GISTs. Family history revealed that some other family members had similar cutaneous pigmentations. Whole-exome sequencing was used to search for potential driver mutations, and Sanger sequencing was used for mutation validation. A novel primary driver mutation of KIT (c.G2485C, p.A829P) was detected in these hereditary GISTs, which has been reported in some targeted chemotherapy-resistant GISTs. Cell models were subsequently established for the rapid screening of candidate drugs and exploring potential mechanisms. This mutation could lead to cell proliferation and imatinib resistance by ligand-independent activation of KIT; however, ripretinib administration was identified as an applicable targeted therapy for this mutation. The mutation activated the JAK/STAT3 and MAPK/ERK pathways, which could be inhibited by ripretinib administration. To the best of our knowledge, this is the first report of the KIT-A829P mutation in familial GISTs, complementing the pathogenesis of familial GISTs and providing valuable information for the precision treatment of this disease.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Gastrointestinal Stromal Tumors: A Review
    Asija, Aakanksha Prasad
    Mejia, Alex V.
    Prestipino, Anthony
    Pillai, Madhavan V.
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (02) : E550 - E557
  • [2] Intolerance to Imatinib in Gastrointestinal Stromal Tumors: A Case Report and a Review of Literature
    Akasbi Y.
    Arifi S.
    Brahmi S.A.
    El Mrabet F.Z.
    Mellas N.
    Mernisi F.Z.
    El Mesbahi O.
    Journal of Gastrointestinal Cancer, 2014, 45 (Suppl 1) : 71 - 73
  • [3] Gastrointestinal stromal tumors: report of an audit and review of the literature
    Biasco, Guido
    Velo, Daniela
    Angriman, Imerio
    Astorino, Maria
    Baldan, Anna
    Baseggio, Matteo
    Basso, Umberto
    Battaglia, Giorgio
    Bertin, Matteo
    Bertorelle, Roberta
    Bocus, Paolo
    Brosolo, Piero
    Bulzacchi, Andrea
    Cannizzaro, Renato
    Da Dalt, Gian Franco
    Di Battista, Monica
    Errante, Domenico
    Fedrigo, Marny
    Frustaci, Sergio
    Lionetti, Ivana
    Massani, Marco
    Mencarelli, Roberto
    Montesco, Maria Cristina
    Norberto, Lorenzo
    Pantaleo, Maria Abbondanza
    Pasquali, Claudio
    Pastorelli, Davide
    Rossi, Carlo Remigio
    Ruffolo, Cesare
    Salvagno, Luigi
    Saponara, Maria Stella
    Vittadello, Fabrizio
    Zaccaria, Francesco
    Zovato, Stefania
    Farinati, Fabio
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2009, 18 (02) : 106 - 116
  • [4] Gastrointestinal Stromal Tumors (GISTs) in Pediatric Patients: A Case Report and Literature Review
    Popoiu, Tudor-Alexandru
    Pirvu, Catalin-Alexandru
    Popoiu, Calin-Marius
    Iacob, Emil Radu
    Talpai, Tamas
    Voinea, Amalia
    Albu, Razvan-Sorin
    Taban, Sorina
    Balanoiu, Larisa-Mihaela
    Pantea, Stelian
    CHILDREN-BASEL, 2024, 11 (09):
  • [5] The Role of Regorafenib in the Management of Advanced Gastrointestinal Stromal Tumors: A Systematic Review
    Khachatryan, Vahe
    Muazzam, Asmaa
    Hamal, Chandani
    Velugoti, Lakshmi Sai Deepak Reddy
    Tabowei, Godfrey
    Gaddipati, Greeshma N.
    Mukhtar, Maria
    Alzubaidee, Mohammed J.
    Dwarampudi, Raga Sruthi
    Mathew, Sheena
    Bichenapally, Sumahitha
    Mohammed, Lubna
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [6] Case Report: Should Regorafenib be prescribed as a continuous schedule in gastrointestinal stromal tumors? Three case reports on Regorafenib personalized schedule
    Grimaudo, Maria Susanna
    Laffi, Alice
    Gennaro, Nicolo
    Fazio, Roberta
    D'Orazio, Federico
    Sama, Laura
    Siracusano, Licia Vanessa
    Sicoli, Federico
    Renne, Salvatore Lorenzo
    Santoro, Armando
    Bertuzzi, Alexia Francesca
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] Gastrointestinal stromal tumors of the small intestine in pediatric populations: a case report and literature review
    Shimomura, Manabu
    Ikeda, Satoshi
    Takakura, Yuji
    Kawaguchi, Yasuo
    Tokunaga, Masakazu
    Takeda, Haruka
    Sumitani, Daisuke
    Yoshimitsu, Masanori
    Hinoi, Takao
    Okajima, Masazumi
    Ohdan, Hideki
    PEDIATRIC SURGERY INTERNATIONAL, 2010, 26 (06) : 649 - 654
  • [8] Gastrointestinal Stromal Tumors A Review of the Literature
    Laurini, Javier A.
    Carter, J. Elliot
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2010, 134 (01) : 134 - 141
  • [9] Gastrointestinal stromal tumors: five case reports and review of the literature
    Torretta, A.
    Prosperi, A.
    Saragani, C.
    Saggese, N.
    Martino, M.
    Fortunato, C.
    Battista, D.
    Capone, F.
    Cacciatore, G.
    De Berardinis, O.
    GIORNALE DI CHIRURGIA, 2006, 27 (11-12): : 405 - 410
  • [10] Peritoneal Carcinomatosis as an Initial Presentation of Gastrointestinal Stromal Tumor: A Case Report and Review of the Literature
    Ozcan, Gonca
    Gautam, Garima
    Da Cunha, Teresa
    Becker, Erica C.
    Perosevic, Nikola
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)